From October 3, 2022 to December 31, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 153,169,445 shares, representing 2.71% for $6,697.75 million under the buyback announced on December 14, 2018.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.98 USD | +1.64% | +5.76% | +4.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.15% | 167B | |
+57.00% | 848B | |
+31.64% | 627B | |
-0.06% | 363B | |
+15.39% | 318B | |
+12.65% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.22% | 179B | |
+2.52% | 125B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Tranche Update on Pfizer Inc.'s Equity Buyback Plan announced on December 14, 2018.